A Phase 3 Study to Compare the Efficacy and Safety of Co-administered HGP0608, HGP0904 and HCP1306 Versus HCP1701 in Patients With Hypertension and Dyslipidemia
Clinical trial NCT04074551 · COMPLETED
Trial details
- NCT number
- NCT04074551
- Sponsor
- Hanmi Pharmaceutical Company Limited
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2019-07-16
- Primary completion
- 2020-03-17
- Enrollment
- 145
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.